MDxHealth (MDXH) Operating Income (2021 - 2026)

MDxHealth has disclosed Operating Income across 6 years of filings, most recently posting $7.3 million for Q1 2026.

• Operating Income for Q1 2026 came in at $7.3 million, up 59.18% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.5 million (up 81.4% YoY), and the FY2025 annual result was -$14.4 million, up 41.72% from the prior year.
• Operating Income came in at $7.3 million for Q1 2026 at MDxHealth, up from -$5.3 million in the prior quarter.
• In the past five years, Operating Income ranged from a high of $26.1 million in Q1 2023 to a low of -$17.7 million in Q2 2023.
• The 5-year median for Operating Income is -$5.3 million (2025), against an average of -$1.7 million.
• Peak annual rise in Operating Income reached 433.0% in 2023, while the deepest fall reached 171.29% in 2023.
• MDxHealth's Operating Income stood at -$8.9 million in 2022, then gained by 29.52% to -$6.3 million in 2023, then grew by 26.93% to -$4.6 million in 2024, then retreated by 14.19% to -$5.3 million in 2025, then jumped by 238.79% to $7.3 million in 2026.
• The last three Operating Income figures came in at $7.3 million (Q1 2026), -$5.3 million (Q4 2025), and -$2.6 million (Q3 2025), per Business Quant data.